← Back to Clinical Trials
RecruitingNCT07197801

Evaluation of a Peer Recovery Support Program Adapted to Target Retention in Clinic-based Medication for Opioid Use Disorder Treatment

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionOpioid Use Disorder
SponsorGeisinger Clinic
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment218
SexALL
Min Age18 Years
Max Age89 Years
Start Date2025-12-23
Completion2029-01-31
Interventions
Peer recovery support to enhance patient engagement in medication for opioid use disorder treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if receiving peer recovery support (support services provided by trained "peers" with lived experience of addiction and recovery) improves retention in medication treatment among people with opioid use disorder. The main question it aims to answer is: does peer recovery support improve retention in medication treatment for opioid use disorder? Researchers will compare two groups: (1) standard care combined with a peer recovery support program, and (2) standard care alone, to see if peer recovery support works to improve retention in medication treatment for opioid use disorder. Participants will: visit clinics as they normally would to receive standard care (medication treatment for opioid use disorder); complete two questionnaires - one when they start treatment and one 6 months later; and agree to let researchers use information from their medical record. Participants in group 1 will also be invited to meet with a peer recovery support specialist for up to 6 months.

Eligibility Criteria

Inclusion Criteria: * Adult ≥ 18 years of age * Initiated medication for opioid use disorder treatment in past 45 days in a Geisinger outpatient clinic * Willing and able to give informed consent Exclusion Criteria: * Received medication for opioid use disorder treatment at a Geisinger outpatient clinic in the 90-day period prior to the treatment initiation date * Not proficient in English

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology